ASRS
FDMT icon

Arizona State Retirement System’s 4D Molecular Therapeutics FDMT Stock Holding History

Arizona State Retirement System’s Portfolio FDMT Stock Details FDMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-7,458
Closed -$238K – 2120
2024
Q1 		$238K Buy
+7,458
New +$190K ﹤0.01% 1841

Other funds holding FDMT

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Arizona State Retirement System's FDMT Position: Q2 2024 in Review

Arizona State Retirement System sold out of 4D Molecular Therapeutics (FDMT) in Q2 2024, closing a stake of 7,458 shares — an estimated $238K sold.

Arizona State Retirement System first reported a position in FDMT in Q1 2024 and held it in 1 quarter. The position peaked at $238K in Q1 2024. 143 funds tracked by Wall St. Rank hold FDMT as of Q2 2024.

  • Arizona State Retirement System reported no remaining 4D Molecular Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Arizona State Retirement System sold 7,458 4D Molecular Therapeutics shares in Q2 2024, an estimated $238K.
  • Arizona State Retirement System first reported a position in 4D Molecular Therapeutics in Q1 2024 and held it in 1 quarter.
  • Arizona State Retirement System's 4D Molecular Therapeutics position peaked at $238K in Q1 2024.
  • 143 funds tracked by Wall St. Rank held 4D Molecular Therapeutics as of Q2 2024.

Based on Arizona State Retirement System's 13F filing for Q2 2024, filed 5 Aug 2024.